Noble Dental Laboratories Ltd - Accounts to registrar (filleted) - small 18.2

Noble Dental Laboratories Ltd - Accounts to registrar (filleted) - small 18.2


IRIS Accounts Production v19.2.0.596 SC398955 director 1.4.18 31.3.19 31.3.19 false true false false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureSC3989552018-03-31SC3989552019-03-31SC3989552018-04-012019-03-31SC3989552017-03-31SC3989552017-04-012018-03-31SC3989552018-03-31SC398955ns14:PoundSterling2018-04-012019-03-31SC398955ns10:Director12018-04-012019-03-31SC398955ns10:PrivateLimitedCompanyLtd2018-04-012019-03-31SC398955ns10:SmallEntities2018-04-012019-03-31SC398955ns10:AuditExempt-NoAccountantsReport2018-04-012019-03-31SC398955ns10:SmallCompaniesRegimeForDirectorsReport2018-04-012019-03-31SC398955ns10:SmallCompaniesRegimeForAccounts2018-04-012019-03-31SC398955ns10:FullAccounts2018-04-012019-03-31SC39895512018-04-012019-03-31SC398955ns5:CurrentFinancialInstruments2019-03-31SC398955ns5:CurrentFinancialInstruments2018-03-31SC398955ns5:Non-currentFinancialInstruments2019-03-31SC398955ns5:Non-currentFinancialInstruments2018-03-31SC398955ns5:ShareCapital2019-03-31SC398955ns5:ShareCapital2018-03-31SC398955ns5:RetainedEarningsAccumulatedLosses2019-03-31SC398955ns5:RetainedEarningsAccumulatedLosses2018-03-31SC398955ns5:NetGoodwill2018-04-012019-03-31SC398955ns5:PlantMachinery2018-04-012019-03-31SC398955ns5:NetGoodwill2018-03-31SC398955ns5:NetGoodwill2019-03-31SC398955ns5:NetGoodwill2018-03-31SC398955ns5:PlantMachinery2018-03-31SC398955ns5:PlantMachinery2019-03-31SC398955ns5:PlantMachinery2018-03-31SC398955ns5:PlantMachineryns5:LeasedAssetsHeldAsLessee2018-03-31SC398955ns5:PlantMachineryns5:LeasedAssetsHeldAsLessee2018-04-012019-03-31SC398955ns5:PlantMachineryns5:LeasedAssetsHeldAsLessee2019-03-31SC398955ns5:PlantMachineryns5:LeasedAssetsHeldAsLessee2018-03-31SC398955ns5:LeasedAssetsHeldAsLessee2018-04-012019-03-31SC398955ns5:CurrentFinancialInstrumentsns5:WithinOneYear2019-03-31SC398955ns5:CurrentFinancialInstrumentsns5:WithinOneYear2018-03-31


REGISTERED NUMBER: SC398955















NOBLE DENTAL LABORATORIES LTD

UNAUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2019






NOBLE DENTAL LABORATORIES LTD (REGISTERED NUMBER: SC398955)






CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2019




Page

Balance Sheet 1

Notes to the Financial Statements 3


NOBLE DENTAL LABORATORIES LTD (REGISTERED NUMBER: SC398955)

BALANCE SHEET
31 MARCH 2019

2019 2018
Notes £    £    £    £   
FIXED ASSETS
Intangible assets 4 80,000 96,000
Tangible assets 5 8,090 10,175
88,090 106,175

CURRENT ASSETS
Stocks 2,000 2,000
Debtors 6 14,056 24,053
Cash in hand - 203
16,056 26,256
CREDITORS
Amounts falling due within one year 7 106,399 122,920
NET CURRENT LIABILITIES (90,343 ) (96,664 )
TOTAL ASSETS LESS CURRENT
LIABILITIES

(2,253

)

9,511

CREDITORS
Amounts falling due after more than one
year

8

-

(5,337

)

PROVISIONS FOR LIABILITIES (1,537 ) (1,933 )
NET (LIABILITIES)/ASSETS (3,790 ) 2,241

CAPITAL AND RESERVES
Called up share capital 1 1
Retained earnings (3,791 ) 2,240
SHAREHOLDERS' FUNDS (3,790 ) 2,241

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2019.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2019 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies
Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end
of each financial year and of its profit or loss for each financial year in accordance with the requirements of
Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to
financial statements, so far as applicable to the company.

NOBLE DENTAL LABORATORIES LTD (REGISTERED NUMBER: SC398955)

BALANCE SHEET - continued
31 MARCH 2019


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Profit and Loss Account has not been delivered.

The financial statements were approved by the director on 29 October 2019 and were signed by:





D T R Noble - Director


NOBLE DENTAL LABORATORIES LTD (REGISTERED NUMBER: SC398955)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2019

1. STATUTORY INFORMATION

Noble Dental Laboratories Ltd is a private company, limited by shares, registered in Scotland. The registered
office is Caledonia House, 89 Seaward Street, Glasgow, G41 1HJ.

The financial statements are presented in Sterling (£).

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with the provisions of Section 1A "Small
Entities" of Financial reporting Standard 102 "The Financial Reporting Standard applicable in the UK and
Republic of Ireland" and the Companies Act 2006. There were no material departures from that standard. The
financial statements have been prepared under the historical cost convention.

The financial statements have been prepared on a going concern basis. The validity of this is dependant on
continued support from the director. If support was to be withdrawn, adjustments may have to be made to
reduce the value of the assets to their recoverable amount and to provide for any further liabilities that may
arise. The director considers however, that it is still appropriate to prepare the financial statements on a going
concern basis despite this uncertainty.

Judgements
The company considers on an annual basis the judgements that are made by management when applying its
significant accounting policies that would have the most significant effect on amounts that are recognised in
the financial statements

The director considers there to be no such significant judgements.

Provisions
Provisions are recognised when the company has a legal or constructive obligation at the reporting date as a
result of a past event, it is probable that the company will be required to settle the obligation and the amount of
the obligation can be reliably estimated. Provisions are recognised at the best estimate of the amount required
to settle the obligation at the reporting date.

Turnover
Turnover comprises the invoiced cost of goods and services sold during the year. The company's policy is to
recognise a sale when substantively all the risks and rewards in connection with the goods and services have
been passed to the buyer.

Goodwill
Positive purchased goodwill arising on acquisitions is capitalised, classified as an asset on the balance sheet
and amortised over its estimated useful life up to a maximum of 10 years. This length of time is presumed to
be the maximum useful life of purchased goodwill because it is difficult to make projections beyond this period.
Goodwill is reviewed for impairment at the end of the first full financial year following each acquisition and
subsequently as and when necessary if circumstances emerge that indicate that the carrying value may not be
recoverable.

NOBLE DENTAL LABORATORIES LTD (REGISTERED NUMBER: SC398955)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2019

2. ACCOUNTING POLICIES - continued

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off the cost less estimated residual value of each asset over its estimated useful life or, if held under a finance lease, over the lease term, whichever is the shorter.
Plant and machinery etc - 25% on reducing balance and 10% to 20% on cost

Fixed assets are included in the balance sheet at cost less accumulated depreciation and accumulated
impairment losses.

Impairment of non-financial assets
At each reporting date non-financial assets not carried at fair value, like goodwill and plant, property and
equipment, are reviewed to determine whether there is an indication that an asset may be impaired. If there is
an indication of possible impairment, the recoverable amount which is the higher of value in use and the fair
value less cost to sell, is estimated and compared with the carrying amount. If the recoverable amount is
lower, the carrying amount of the asset is reduced to its recoverable amount and an impairment loss is
recognised immediately in profit and loss.

Stocks
Stocks are valued at the lower of cost and estimated selling price less costs to sell.

Financial instruments
The company only enters into basic financial instruments transactions that result in the recognition of financial
assets and liabilities like trade and other accounts receivable and payable, loans from banks and loans to
related parties.

Debt instruments like loans and other accounts receivable and payable are initially measured at present value
of the future payments and subsequently at amortised cost using the effective interest method. Debt
instruments that are payable or receivable within one year, typically trade debtors and trade creditors, are
measured, initially and subsequently, at the undiscounted amount of cash or other consideration expected to be
paid or received.

Taxation
Taxation represents the sum of tax currently payable and deferred tax. The company's liability for current tax is
calculated using tax rates that have been enacted or substantively enacted by the end of the reporting period.

The charge for taxation takes into account taxation deferred as a result of timing differences between the
treatment of certain items for taxation and accounting purposes. In general, deferred taxation is recognised in
respect of all timing differences that have originated but not reversed at the balance sheet date. However,
deferred tax assets are recognised only to the extent that the director considers that it is more likely than not
that there will be suitable taxable profits from which the future reversal of the underlying timing differences
can be deducted. Deferred taxation is measured on a non-discounted basis at the tax rates that are expected to
apply in the periods in which the timing differences reverse, based on tax rates and laws enacted or
substantively enacted at the balance sheet date.

With the exception of changes arising on the initial recognition of a business combination, the tax expense is
presented either in profit or loss, other comprehensive income or statement of changes in equity depending on
the transaction that resulted in the tax expense.

Deferred tax liabilities are presented within provisions for liabilities and deferred tax assets within debtors.

NOBLE DENTAL LABORATORIES LTD (REGISTERED NUMBER: SC398955)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2019

2. ACCOUNTING POLICIES - continued

Hire purchase and leasing commitments
Assets obtained under hire purchase contracts or finance leases are capitalised in the balance sheet. Those held
under hire purchase contracts are depreciated over their estimated useful lives. Those held under finance
leases are depreciated over their estimated useful lives or the lease term, whichever is the shorter.

The interest element of these obligations is charged to profit or loss over the relevant period. The capital
element of the future payments is treated as a liability.

Rentals paid under operating leases are charged to the profit and loss account on a straight line basis over the
period of the lease.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension
scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 8 (2018 - 9 ) .

4. INTANGIBLE FIXED ASSETS
Goodwill
£   
COST
At 1 April 2018
and 31 March 2019 160,000
AMORTISATION
At 1 April 2018 64,000
Charge for year 16,000
At 31 March 2019 80,000
NET BOOK VALUE
At 31 March 2019 80,000
At 31 March 2018 96,000

NOBLE DENTAL LABORATORIES LTD (REGISTERED NUMBER: SC398955)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2019

5. TANGIBLE FIXED ASSETS
Plant and
machinery
etc
£   
COST
At 1 April 2018 19,601
Additions 610
At 31 March 2019 20,211
DEPRECIATION
At 1 April 2018 9,426
Charge for year 2,695
At 31 March 2019 12,121
NET BOOK VALUE
At 31 March 2019 8,090
At 31 March 2018 10,175

Fixed assets, included in the above, which are held under hire purchase contracts are as follows:

Plant and
machinery
etc
£   
COST
At 1 April 2018
and 31 March 2019 15,428
DEPRECIATION
At 1 April 2018 6,750
Charge for year 2,169
At 31 March 2019 8,919
NET BOOK VALUE
At 31 March 2019 6,509
At 31 March 2018 8,678

These assets are held as security against hire purchase obligations.

6. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2019 2018
£    £   
Trade debtors 13,953 24,053
Other debtors 103 -
14,056 24,053

NOBLE DENTAL LABORATORIES LTD (REGISTERED NUMBER: SC398955)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2019

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2019 2018
£    £   
Bank loans and overdrafts 12,138 9,309
Hire purchase contracts 5,337 3,202
Trade creditors 9,231 7,172
Taxation and social security 10,387 8,181
Other creditors 69,306 95,056
106,399 122,920

8. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE
YEAR
2019 2018
£    £   
Hire purchase contracts - 5,337

9. SECURED DEBTS

The following secured debts are included within creditors:

2019 2018
£    £   
Hire purchase contracts 5,337 8,539

Hire purchase liabilities are secured over the assets to which the contracts relate.

10. RELATED PARTY DISCLOSURES

At the year end, included in creditors, is an amount due to the director totalling £55,481 (2018 - £83,403).
This amount is interest free, unsecured and has no fixed repayment terms.